Network Pharmacology-Based Approach to Comparatively Predict the Active Ingredients and Molecular Targets of Compound Xueshuantong Capsule and Hexuemingmu Tablet in the Treatment of Proliferative Diabetic Retinopathy

<div>Topological screening process of the protein-protein interaction (PPI) networks. Left: original PPI network; middle: PPI network after the first screen; right: PPI network after the second screen. (a) Screening process of the compound Xueshuantong capsule. (b) Screening process of the Hexuemingmu tablet.</div>

Evidence-Based Complementary and Alternative Medicine

fig5

Figure 5

Figure 5: Network Pharmacology-Based Approach to Comparatively Predict the Active Ingredients and Molecular Targets of Compound Xueshuantong Capsule and Hexuemingmu Tablet in the Treatment of Proliferative Diabetic Retinopathy 

Figure 5 | Network Pharmacology-Based Approach to Comparatively Predict the Active Ingredients and Molecular Targets of Compound Xueshuantong Capsule and Hexuemingmu Tablet in the Treatment of Proliferative Diabetic Retinopathy 